Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted Gross Margin of 55.52% for Q4 2025, little changed on a QoQ basis from 55.3% in Q3 2025, and up 5.0% year-over-year from 52.88% in Q4 2024.
Analysis
Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare has reported Gross Margin for 16 years, with the latest figure at 55.52% in Q4 2025.
- On a quarterly basis, Gross Margin rose 5.0% year-over-year to 55.52% in Q4 2025; TTM through Dec 2025 was 56.12%, a 100.0% increase from a year earlier, with the FY2025 full-year figure at 55.76%, up 28.0% from the prior year.
- Gross Margin was 55.52% for Q4 2025 at Prestige Consumer Healthcare, roughly flat from 55.3% in the prior quarter.
- The five-year high for Gross Margin was 59.07% in Q2 2021, with the low at 53.79% in Q1 2023.
- Average Gross Margin over 5 years is 55.99%, with a median of 55.71% recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Gross Margin sank 242 bps in 2023, then soared 253 bps in 2025.
- Over 5 years, Gross Margin stood at 56.49% in 2021, then retreated by 3 bps to 54.59% in 2022, then gained by 2 bps to 55.86% in 2023, then declined by 1 bps to 55.47% in 2024, then grew by 0 bps to 55.52% in 2025.
- The last three Gross Margin figures came in at 55.52% (Q4 2025), 55.3% (Q3 2025), and 56.24% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 61.48% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 58.18% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 38.27% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 45.71% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 30.69% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 77.67% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 42.54% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 48.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 55.52% |
| Sep 30, 2025 | 55.30% |
| Jun 30, 2025 | 56.24% |
| Mar 31, 2025 | 57.34% |
| Dec 31, 2024 | 55.47% |
| Sep 30, 2024 | 55.46% |
| Jun 30, 2024 | 54.66% |
| Mar 31, 2024 | 54.81% |
| Dec 31, 2023 | 55.86% |
| Sep 30, 2023 | 55.89% |
| Jun 30, 2023 | 55.38% |
| Mar 31, 2023 | 53.79% |
| Dec 31, 2022 | 54.59% |
| Sep 30, 2022 | 55.66% |
| Jun 30, 2022 | 57.79% |
| Mar 31, 2022 | 55.77% |
| Dec 31, 2021 | 56.49% |
| Sep 30, 2021 | 57.10% |
| Jun 30, 2021 | 59.07% |
| Mar 31, 2021 | 57.64% |